References
- Lin EY, Li JF, Gnatovskiy L, Deng Y, Zhu L, Grzesik DA, et al. Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 2006;66(23):11238–46. doi:https://doi.org/10.1158/0008-5472.CAN-06-1278.
- He H, Chiu AC, Kanada M, Schaar BT, Krishnan V, Contag CH, et al. Imaging of tumor-associated macrophages in a transgenic mouse model of orthotopic ovarian cancer. Mol Imaging Biol. 2017;19(5):694–702. doi:https://doi.org/10.1007/s11307-017-1061-2.
- Nishide S, Matsunaga S, Shiota M, Yamaguchi T, Kitajima S, Maekawa Y, et al. Controlling the phenotype of tumor-infiltrating macrophages via the PHD-HIF axis inhibits tumor growth in a mouse model. iScience. 2019;21:205. doi:https://doi.org/10.1016/j.isci.2019.08.033
- Bartneck M, Schrammen PL, Möckel D, Govaere O, Liepelt A, Krenkel O, et al. The CCR2+ macrophage subset promotes pathogenic angiogenesis for tumor vascularization in fibrotic livers. Cell Mol Gastroenterol Hepatol. 2019;7(2):371–90. doi:https://doi.org/10.1016/j.jcmgh.2018.10.007.
- Zhang J, Yan Y, Yang Y, Wang L, Li M, Wang J, et al. High infiltration of tumor-associated macrophages influences poor prognosis in human gastric cancer patients, associates with the phenomenon of. EMT. Med. 2016;95(6):1–6. doi:https://doi.org/10.2147/OTT.S61838.
- Yuan ZY, Luo RZ, Peng RJ, Wang S, Sen , Xue C. High infiltration of tumor-associated macrophages in triple-negative breast cancer is associated with a higher risk of distant metastasis. Onco Targets Ther. 2014;7:1475–80. doi:https://doi.org/10.2147/OTT.S61838.
- Liu T, Larionova I, Litviakov N, Riabov V, Zavyalova M, Tsyganov M, et al. Tumor-associated macrophages in human breast cancer produce new monocyte attracting and pro-angiogenic factor YKL-39 indicative for increased metastasis after neoadjuvant chemotherapy. Oncoimmunology. 2018;7(6):e1436922. doi:https://doi.org/10.1080/2162402X.2018.1436922.
- Zhang H, Wang X, Shen Z, Xu J, Qin J, Sun Y. Infiltration of diametrically polarized macrophages predicts overall survival of patients with gastric cancer after surgical resection. Gastric Cancer. 2015;18(4):740–50. doi:https://doi.org/10.1007/s10120-014-0422-7.
- Zhang W, Wang X, Gao S, Chen C, Xu X, Sun Q, et al. Tumor-associated macrophages correlate with phenomenon of epithelial-mesenchymal transition and contribute to poor prognosis in triple-negative breast cancer patients. J Surg Res. 2018;222:93–101. doi:https://doi.org/10.1016/j.jss.2017.09.035.
- Thorn AP, Daugaard S, Christensen LH, Christensen IJ, Petersen MM. YKL-40 protein in osteosarcoma tumor tissue. APMIS. 2016;124(6):453–461. doi:https://doi.org/10.1111/apm.12524.
- Sica A, Saccani A, Mantovani A. Tumor-associated macrophages: a molecular perspective. Int Immunopharmacol. 2002;2(8):1045–1054. doi:https://doi.org/10.1016/s1567-5769(02)00064-4.
- Qian B, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell. 2010;141(1):39–51. doi:https://doi.org/10.1016/j.cell.2010.03.014.
- Hua Y, Bergers G. Tumors vs. chronic wounds: an immune cell’s perspective. Front Immunol. 2019;10(9):2178–11. doi:https://doi.org/10.3389/fimmu.2019.02178
- Cassetta L, Fragkogianni S, Sims AH, Swierczak A, Forrester LM, Zhang H, et al. Human tumor-associated macrophage and monocyte transcriptional landscapes reveal cancer-specific reprogramming, biomarkers, and therapeutic targets. Cancer Cell. 2019;35(4):588–602.e10. doi:https://doi.org/10.1016/j.ccell.2019.02.009.
- Pollard JW. Macrophages define the invasive microenvironment in breast cancer. J Leukoc Biol. 2008;84(3):623–630. doi:https://doi.org/10.1189/jlb.1107762.
- Solís-Martínez R, Cancino-Marentes M, Hernández-Flores G, Ortiz-Lazareno P, Mandujano-Álvarez G, Cruz-Gálvez C, et al. Regulation of immunophenotype modulation of monocytes-macrophages from M1 into M2 by prostate cancer cell-culture supernatant via transcription factor STAT3. Immunol Lett. 2018;196:140–148. doi:https://doi.org/10.1016/j.imlet.2018.02.009.
- Yang Q, Wei J, Zhong L, Shi M, Zhou P, Zuo S, et al. Cross talk between histone deacetylase 4 and STAT6 in the transcriptional regulation of arginase 1 during mouse dendritic cell differentiation. Mol Cell Biol. 2015;35(1):63–75. doi:https://doi.org/10.1128/MCB.00805-14.
- Goenka S, Kaplan MH. Transcriptional regulation by STAT6. Immunol Res. 2011;50(1):87–96. doi:https://doi.org/10.1007/s12026-011-8205-2.
- Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A. IL-13 signaling through the IL-13alpha2 receptor is involved in induction of TGF-beta1 production and fibrosis. Nat Med. 2006;12(1):99–106. doi:https://doi.org/10.1038/nm1332.
- Casella G, Garzetti L, Gatta AT, Finardi A, Maiorino C, Ruffini F, et al. IL4 induces IL6-producing M2 macrophages associated to inhibition of neuroinflammation in vitro and in vivo. J Neuroinflammation. 2016;13(1):1–10. doi:https://doi.org/10.1186/s12974-016-0596-5.
- Wu W, Llewellyn OPC, Bates DO, Nicholson LB, Dick AD. Immunobiology IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxia. Immunobiology. 2010;215(9-10):796–803. doi:https://doi.org/10.1016/j.imbio.2010.05.025.
- Sekiguchi K, Ito Y, Hattori K, Inoue T, Hosono K, Honda M, et al. VEGF receptor 1-expressing macrophages recruited from bone marrow enhances angiogenesis in endometrial tissues. Sci Rep. 2019;9(1):1–14. doi:https://doi.org/10.1038/s41598-019-43185-8.
- Forssell J, Öberg Å, Henriksson ML, Stenling R, Jung A, Palmqvist R. High macrophage infiltration along the tumor front correlates with improved survival in colon cancer. Clin Cancer Res. 2007;13(5):1472–1479. doi:https://doi.org/10.1158/1078-0432.CCR-06-2073.
- Hume DA. The many alternative faces of macrophage activation. Front Immunol. 2015;6(6):370–410. doi:https://doi.org/10.3389/fimmu.2015.00370
- Mantovani A, Locati M. Tumor-associated macrophages as a paradigm of macrophage plasticity, diversity, and polarization: lessons and open questions. Arterioscler Thromb Vasc Biol. 2013;33(7):1478–1483. doi:https://doi.org/10.1161/ATVBAHA.113.300168.
- Bögels M, Braster R, Nijland PG, Gü N, van de Luijtgaarden W, Fijneman RJA, et al. Carcinoma origin dictates differential skewing of monocyte function. Oncoimmunology. 2012;1(6):798–809. doi:https://doi.org/10.4161/onci.20427.
- Buldakov M, Zavyalova M, Krakhmal N, Telegina N, Vtorushin S, Mitrofanova I, et al. CD68+, but not stabilin-1+ tumor associated macrophages in gaps of ductal tumor structures negatively correlate with the lymphatic metastasis in human breast cancer. Immunobiology. 2017;222(1):31–38. doi:https://doi.org/10.1016/j.imbio.2015.09.011.
- Yang M, McKay D, Pollard JW, Lewis CE. Diverse functions of macrophages in different tumor microenvironments. Cancer Res. 2018;78(19):5492–5503. doi:https://doi.org/10.1158/0008-5472.CAN-18-1367.
- Wenes M, Shang M, Di Matteo M, Goveia J, Martín-Pérez R, Serneels J, et al. Macrophage metabolism controls tumor blood vessel morphogenesis and metastasis. Cell Metab. 2016;824(5):701–715. doi:https://doi.org/10.1016/j.cmet.2016.09.008.
- Müller S, Kohanbash G, Liu SJ, Alvarado B, Carrera D, Bhaduri A, et al. Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment. Genome Biol. 2017;18(1):1–14. doi:https://doi.org/10.1186/s13059-017-1362-4.
- Henze A, Mazzone M, Henze A, Mazzone M. The impact of hypoxia on tumor-associated macrophages. J Clin Invest. 2016;126(10):3672–3679. doi:https://doi.org/10.1158/2326-6066.CIR-18-0749
- Mantovani A, Allavena P, Sica A. Tumour-associated macrophages as a prototypic type II polarised phagocyte population: Role in tumour progression. Eur J Cancer. 2004;40(11):1660–1667. doi:https://doi.org/10.1016/j.ejca.2004.03.016.
- Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression. Potential targets of anti-cancer therapy. Eur J Cancer. 2006;42:17–27. doi:https://doi.org/10.1016/j.ejca.2006.01.003.
- Stone SC, Ariza R, Rossetti M, Carvalho JP, Baracat EC, Lorenzi NP, et al. Lactate secreted by cervical cancer cells modulates macrophage phenotype. J Leukoc Biol. 2019;105(5):1041–1054. doi:https://doi.org/10.1002/JLB.3A0718-274RR.
- Kapellos TS, Bonaguro L, Gemünd I, Reusch N, Saglam A, Hinkley ER, et al. Human monocyte subsets and phenotypes in major chronic inflammatory diseases. Front Immunol. 2019;10(09):2035–2113. doi:https://doi.org/10.3389/fimmu.2019.02035
- Li L, Sun P, Zhang C, Li Z, Cui K, Zhou W. MiR-98 modulates macrophage polarization and suppresses the effects of tumor-associated macrophages on promoting invasion and epithelial-mesenchymal transition of hepatocellular carcinoma. Cancer Cell Int. 2018;18(1):1–10. doi:https://doi.org/10.1186/s12935-018-0590-3.
- Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, Figueiredo JL, et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med. 2013;19(9):1166–1172. doi:https://doi.org/10.1038/nm.3258.
- Gross-Vered M, Trzebanski S, Shemer A, Bernshtein B, Curato C, Stelzer G, et al. Defining murine monocyte differentiation into colonic and ileal macrophages. Elife. 2020;9:1–19. doi:https://doi.org/10.7554/eLife.49998.
- Jones GR, Bain CC, Fenton TM, Kelly A, Brown SL, Ivens AC, et al. Dynamics of colon monocyte and macrophage activation during colitis. Front Immunol. 2018;9:2764 doi:https://doi.org/10.3389/fimmu.2018.02764.
- Movahedi K, Laoui D, Gysemans C, Baeten M, Stangé G, Bossche J Den V, et al. Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes. Cancer Res. 2010;70(14):5728–5739. doi:https://doi.org/10.1158/0008-5472.CAN-09-4672.
- Hoeksema MA, De Winther MPJ. Epigenetic Regulation of Monocyte and Macrophage Function. Antioxid Redox Signal. 2016;25(14):758–774. doi:https://doi.org/10.1089/ars.2016.6695.
- Lee C, Geng S, Zhang Y, Rahtes A, Li L. Programming and memory dynamics of innate leukocytes during tissue homeostasis and inflammation. J Leukoc Biol. 2017;102(3):719–726. doi:https://doi.org/10.1189/jlb.6MR0117-027RR.
- Litviakov N, Tsyganov M, Larionova I, Ibragimova M, Deryusheva I, Kazantseva P, et al. Expression of M2 macrophage markers YKL-39 and CCL18 in breast cancer is associated with the effect of neoadjuvant chemotherapy. Cancer Chemother Pharmacol. 2018;82(1):99–109. doi:https://doi.org/10.1007/s00280-018-3594-8.
- Madej MP, Töpfer E, Boraschi D, Italiani P. Different regulation of interleukin-1 production and activity in monocytes and macrophages: Innate memory as an endogenous mechanism of IL-1 inhibition. Front Pharmacol. 2017;8:335–412. doi:https://doi.org/10.3389/fphar.2017.00335
- Bassler K, Schulte-Schrepping J, Warnat-Herresthal S, Aschenbrenner AC, Schultze JL. The myeloid cell compartment-cell by cell. Annu Rev Immunol. 2019;37(1):269–293. doi:https://doi.org/10.1146/annurev-immunol-042718-041728.
- Trombetta AC, Soldano S, Contini P, Tomatis V, Ruaro B, Paolino S, et al. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. Respir Res. 2018;19(1):1–12. doi:https://doi.org/10.1186/s12931-018-0891-z.
- Hou J, Zhang M, Ding Y, Wang X, Li T, Gao P, et al. Circulating CD14 + CD163 + CD206+ M2 monocytes are increased in patients with early stage of idiopathic membranous nephropathy. Mediators Inflamm. 2018;2018:5270657. doi:https://doi.org/10.1155/2018/5270657.
- Kzhyshkowska J, Workman G, Cardó-Vila M, Arap W, Pasqualini R, Gratchev A, et al. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol. 2006;176(10):5825–5832. doi:https://doi.org/10.4049/jimmunol.176.10.5825.
- Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45. doi:https://doi.org/10.1093/nar/29.9.e45.
- Kzhyshkowska J, Gratchev A, Schmuttermaier C, Brundiers H, Krusell L, Mamidi S, et al. Alternatively activated macrophages regulate extracellular levels of the hormone placental lactogen via receptor-mediated uptake and transcytosis. J Immunol. 2008;180(5):3028–3037. doi:https://doi.org/10.4049/jimmunol.180.5.3028.
- Mantovani A, Garlanda C, Allavena P. Molecular pathways and targets in cancer-related inflammation. Ann Med. 2010;42(3):161–170. doi:https://doi.org/10.3109/07853890903405753.
- Stakheyeva M, Riabov V, Mitrofanova I, Litviakov N, Choynzonov E, Cherdyntseva N, et al. Role of the immune component of tumor microenvironment in the efficiency of cancer treatment: perspectives for the personalized therapy. Curr Pharm Des. 2017;23:32. doi:https://doi.org/10.2174/1381612823666170714161703.
- Hinshaw DC, Shevde LA. The tumor microenvironment innately modulates cancer progression. Cancer Res. 2019;79(18):4557–4567. doi:https://doi.org/10.1158/0008-5472.CAN-18-3962.
- Zhang B, Cao M, He Y, Liu Y, Zhang G, Yang C, et al. Increased circulating M2-like monocytes in patients with breast cancer. Tumour Biol. 2017;39(6):1010428317711571. doi:https://doi.org/10.1177/1010428317711571.
- Hamm A, Prenen H, Van Delm W, Di Matteo M, Wenes M, Delamarre E, et al. Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer. Gut. 2016;65(6):990–1000. doi:https://doi.org/10.1136/gutjnl-2014-308988.
- Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004;25(12):677–686. doi:https://doi.org/10.1016/j.it.2004.09.015.
- Thomas F, Fisher D, Fort P, Marie JP, Daoust S, Roche B, et al. Applying ecological and evolutionary theory to cancer: A long and winding road. Evol Appl. 2013;6(1):1–10. doi:https://doi.org/10.1111/eva.12021.
- Castro F, Cardoso AP, Gonçalves RM, Serre K, Oliveira MJ. Interferon-gamma at the crossroads of tumor immune surveillance or evasion. Front Immunol. 2018;9:1–19. doi:https://doi.org/10.3389/fimmu.2018.00847.
- Zitvogel L, Tesniere A, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of anticancer chemotherapy. Bull Acad Natl Med. 2008;192(7):1469–1489. doi:https://doi.org/10.1038/nri2216
- Jones SA, Jenkins BJ. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat Rev Immunol. 2018;18(12):773–789. doi:https://doi.org/10.1038/s41577-018-0066-7.
- Gallo M, Frezzetti D, Roma C, Chicchinelli N, Barbieri A, Arra C, et al. RANTES and IL-6 cooperate in inducing a more aggressive phenotype in breast cancer cells. Oncotarget. 2018;9(25):17543–17553. doi:https://doi.org/10.18632/oncotarget.24784.
- Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349–362. doi:https://doi.org/10.1038/nri.2017.28.
- Fasoulakis Z, Kolios G, Papamanolis V, Kontomanolis EN. Interleukins associated with breast cancer. Cureus. 2018;10(11):1–11. doi:https://doi.org/10.7759/cureus.3549.
- Todorović-Raković N, Milovanović J. Interleukin-8 in breast cancer progression. J Interferon Cytokine Res. 2013;33(10):563–570. doi:https://doi.org/10.1089/jir.2013.0023.
- De Giorgi U, Mego M, Scarpi E, Giordano A, Giuliano M, Valero V, et al. Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer. Ther Adv Med Oncol. 2019;11:175883591986606. doi:https://doi.org/10.1177/1758835919866065.